Navigation Links
MRE could provide a definitive diagnosis for people with muscle pain, Mayo Clinic study shows
Date:11/29/2007

ROCHESTER, Minn. -- An estimated nine million men and women in the United States live with myofascial pain syndrome, a condition marked by pain that permeates muscles in the neck, back and shoulders. The condition is difficult to diagnose and not entirely understood, but research studies indicate that a new imaging technology developed at Mayo Clinic holds promise for a definitive diagnosis and, perhaps eventually, new treatments for people who have the syndrome.

A Mayo Clinic study published in the November issue of the Archives of Physical Medicine and Rehabilitation shows that magnetic resonance elastography, or MRE, can provide images of the affected muscle with clarity and insight not possible with magnetic resonance imaging, or MRI. While an MRI uses a magnetic field and radio waves to create clear and detailed cross-sectional images of the bodys internal tissues and organs, an MRE measures the elasticity of tissue as it is gently vibrated.

Additional research is necessary, but our findings in this pilot study provide a strong basis to suspect that MRE technology can identify changes in muscle tone and stiffness that could previously only be identified by physical examination by a physician or a therapist, says Jeffrey Basford, M.D., Ph.D., a Mayo Clinic specialist in physical medicine and rehabilitation and an author of the study. Prior to these findings, we did not have a good diagnostic test for myofascial pain syndrome.

An MRE employs standard MRI equipment with a few modifications, and works by measuring the wavelength of vibrations sent through the tissues. A vibrating metal plate is placed on the patient causing muscles to contract and stiffen. When this occurs, researchers can measure the elasticity of muscles and detect abnormal hardening of tissues, which in myofasical pain syndrome can cause pain.

The MRE technique is being applied to the diagnosis of other diseases, such as liver disease (http://discoverysedge.mayo.edu/de07-1-biotech-ehman/) and could also be used to diagnose breast cancer and other tumors, which tend to be harder than the surrounding normal tissue.

Myofascial pain syndrome is sometimes confused with fibromyalgia, but the two conditions are clinically different. Fibromyalgia is a chronic condition typically characterized by widespread pain in muscles, ligaments and tendons, as well as fatigue and multiple tender points. Myofascial pain syndrome, is a more localized pain that is associated with trigger point tenderness. A trigger point is a small lump in a band of tight muscle that, when pressed, triggers a reproducible pattern of referred pain.

In the past, myofasical pain syndrome has been very difficult to diagnose. These new findings may be the next step for a diagnosis and in the future may help to refine treatment options, Dr. Basford says.

In some chronic cases of myofascial pain, combinations of physical therapy and trigger point injections are needed to relieve pain. In addition, the condition is sometimes treated with the spray and stretch technique, which involves spraying the muscle and trigger point with a coolant and then slowly stretching the muscle.


'/>"/>

Contact: Amy Reyes
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Study provides hope that some transplant patients could live free of antirejection drugs
2. Study provides hope that some transplant patients could live free of anti-rejection drugs
3. HIV denialists spread misinformation online -- consequences could be deadly; and more
4. Virus Could Help Drive Obesity
5. Discovery of sugar sensor in intestine could benefit diabetes
6. Cranberry Could Juice Up Ovarian Cancer Treatment
7. Treating Diabetes During Pregnancy Could Lead to Thinner Kids
8. High-risk behaviors could lead to HIV epidemic in Afghanistan
9. Chinas 1-child policy could backfire on its elderly
10. 1.5 million children could be saved
11. More than 10,000 Medicare Patients in Montana Could Be Hit by Proposed Cuts to Home Oxygen Therapy; Access to Power Wheelchairs Would Also Decrease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... IsoComforter, Inc., one of ... the newly designed, innovative shoulder wrap. The newly designed shoulder wrap has ... injured arm and shoulder to promote faster healing. It is highly recommended for ...
(Date:2/9/2016)... ... 09, 2016 , ... United Methodist Communications collaborated with Chocolate ... animated video designed to prevent the next widespread Ebola outbreak from ... being distributed throughout Togo, Liberia, Sierra Leone, Nigeria, Côte d’Ivoire and other African ...
(Date:2/9/2016)... ... February 09, 2016 , ... i2i Systems, an early innovator and ... data vendors in the latest KLAS report, Population Health Management 2015: How Far Can ... market for population health management (PHM). The latest KLAS Report, leveraging over 200 ...
(Date:2/9/2016)... Ashburn, VA (PRWEB) , ... February 09, 2016 ... ... ) Small Mammal Prize has officially been won. A team from 21st Century ... has discovered a way to preserve the delicate neural circuits of an intact ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... redesigned website, federallabs.org . The site houses a wealth of federal resources ... technologies through the process called technology transfer (T2). As a network of over ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... disease and heart failure, today announced that it intends to ... stock in an underwritten public offering.  The offering is subject ... assurance as to whether or when the offering may be ... the offering.   --> --> ...
(Date:2/9/2016)... 9, 2016 The new report "Global Diagnostic Ultrasound Devices ... Consulting group reveals that global diagnostic ultrasound devices market was valued ... US$ 7,466.3 million by 2019 at a CAGR of 6.8% from ... ultrasound market has been analyzed for six geographies of ... Asia-Pacific , Latin America , ...
(Date:2/9/2016)... , Feb. 9, 2016 The leader ... that AcceleDent ® is the recipient of the ... category. An FDA-cleared, Class II medical device that speeds ... percent and relieves pain often associated with treatment, AcceleDent ... participated in the annual Orthotown survey of ...
Breaking Medicine Technology: